Adipogenesis: cellular and molecular aspects.
暂无分享,去创建一个
[1] J. Gimble,et al. Response of bone marrow stromal cells to adipogenic antagonists , 1989, Molecular and cellular biology.
[2] P. Stewart,et al. Cortisol, 11β-hydroxysteroid dehydrogenase type 1 and central obesity , 2002, Trends in Endocrinology & Metabolism.
[3] C. Verfaillie,et al. Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain. , 2002, Experimental hematology.
[4] C. Dani,et al. Transplantation of a multipotent cell population from human adipose tissue induces dystrophin expression in the immunocompetent mdx mouse , 2005, The Journal of experimental medicine.
[5] R Busse,et al. Improvement of Postnatal Neovascularization by Human Adipose Tissue–Derived Stem Cells , 2004, Circulation.
[6] M. Desai,et al. Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.
[7] T. Olsson,et al. Tissue-specific dysregulation of cortisol metabolism in human obesity. , 2001, The Journal of clinical endocrinology and metabolism.
[8] J. Lehmann,et al. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation , 1995, Cell.
[9] L. Casteilla,et al. Transplantation of Adipose Tissue-Derived Stromal Cells Increases Mass and Functional Capacity of Damaged Skeletal Muscle , 2004, Cell transplantation.
[10] H. Green,et al. An established preadipose cell line and its differentiation in culture II. Factors affecting the adipose conversion , 1975, Cell.
[11] C. Verfaillie. Adult stem cells: assessing the case for pluripotency. , 2002, Trends in cell biology.
[12] Haiyan Xu,et al. Exclusive Action of Transmembrane TNFα in Adipose Tissue Leads to Reduced Adipose Mass and Local But Not Systemic Insulin Resistance. , 2002, Endocrinology.
[13] C. Remacle,et al. Interferon‐γ and interleukin‐1β inhibit adipoconversion in cultured rodent preadipocytes , 1992, Journal of cellular physiology.
[14] B. Spiegelman,et al. Regulation of Peroxisome Proliferator-Activated Receptor γ Expression by Adipocyte Differentiation and Determination Factor 1/Sterol Regulatory Element Binding Protein 1: Implications for Adipocyte Differentiation and Metabolism , 1999, Molecular and Cellular Biology.
[15] M. Lazar,et al. The hormone resistin links obesity to diabetes , 2001, Nature.
[16] J. Hirsch,et al. Demonstration of de novo production of adipocytes in adult rats by biochemical and radioautographic techniques. , 1984, Journal of lipid research.
[17] Catherine M. Verfaillie,et al. Pluripotency of mesenchymal stem cells derived from adult marrow , 2002, Nature.
[18] E. Furfine,et al. HIV protease inhibitors block adipogenesis and increase lipolysis in vitro. , 2000, Antiviral research.
[19] M. Wabitsch,et al. LiSa‐2, a novel human liposarcoma cell line with a high capacity for terminal adipose differentiation , 2000, International journal of cancer.
[20] J. Hirsch,et al. Diet-induced adipocyte number increase in adult rats: a new model of obesity. , 1978, The American journal of physiology.
[21] M. Lazar,et al. Regulation of Fasted Blood Glucose by Resistin , 2004, Science.
[22] M. Lazar,et al. Prostaglandins Promote and Block Adipogenesis through Opposing Effects on Peroxisome Proliferator-activated Receptor γ* , 1998, The Journal of Biological Chemistry.
[23] P. Carlsson,et al. FOXC2 Is a Winged Helix Gene that Counteracts Obesity, Hypertriglyceridemia, and Diet-Induced Insulin Resistance , 2001, Cell.
[24] Bruce M. Spiegelman,et al. Inhibition of Adipogenesis Through MAP Kinase-Mediated Phosphorylation of PPARγ , 1996, Science.
[25] P. Lucas,et al. Wnt10b Inhibits Development of White and Brown Adipose Tissues* , 2004, Journal of Biological Chemistry.
[26] G. Yancopoulos,et al. Ciliary neurotrophic factor activates leptin-like pathways and reduces body fat, without cachexia or rebound weight gain, even in leptin-resistant obesity , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[27] S. Freytag,et al. Ectopic expression of the CCAAT/enhancer-binding protein alpha promotes the adipogenic program in a variety of mouse fibroblastic cells. , 1994, Genes & development.
[28] C. Darimont,et al. Reconstitution of telomerase activity combined with HPV-E7 expression allow human preadipocytes to preserve their differentiation capacity after immortalization , 2003, Cell Death and Differentiation.
[29] J. Flier,et al. A Transgenic Model of Visceral Obesity and the Metabolic Syndrome , 2001, Science.
[30] L. Pénicaud,et al. Spontaneous Cardiomyocyte Differentiation From Adipose Tissue Stroma Cells , 2004, Circulation research.
[31] C. Mantzoros,et al. Human Immunodeficiency Virus/Highly Active Antiretroviral Therapy-Associated Metabolic Syndrome: Clinical Presentation, Pathophysiology, and Therapeutic Strategies , 2003 .
[32] G. Firestone,et al. Role of the CCAAT/Enhancer Binding Protein-α Transcription Factor in the Glucocorticoid Stimulation of p21 waf1/cip1 Gene Promoter Activity in Growth-arrested Rat Hepatoma Cells* , 1998, The Journal of Biological Chemistry.
[33] J. Lenhard,et al. Select HIV Protease Inhibitors Alter Bone and Fat Metabolismex Vivo * , 2002, The Journal of Biological Chemistry.
[34] C. Dani,et al. The extracellular signal-regulated kinase isoform ERK1 is specifically required for in vitro and in vivo adipogenesis. , 2005, Diabetes.
[35] J. Ward,et al. Growth, Adipose, Brain, and Skin Alterations Resulting from Targeted Disruption of the Mouse Peroxisome Proliferator-Activated Receptor β(δ) , 2000, Molecular and Cellular Biology.
[36] J. Nevins,et al. The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F. , 1992, Genes & development.
[37] J. Berger,et al. Inhibition of adipocyte differentiation by HIV protease inhibitors. , 1999, The Journal of clinical endocrinology and metabolism.
[38] J. Stephens,et al. The Regulation and Activation of Ciliary Neurotrophic Factor Signaling Proteins in Adipocytes* , 2003, The Journal of Biological Chemistry.
[39] B. Spiegelman,et al. PPARγ Is Required for the Differentiation of Adipose Tissue In Vivo and In Vitro , 1999 .
[40] S. McKnight,et al. Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins. , 1995, Genes & development.
[41] B. Spiegelman,et al. ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism. , 1996, Genes & development.
[42] W. Rozenbaum,et al. Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance , 2002, The Lancet.
[43] S. Luquet,et al. Alterations of Peroxisome Proliferator-activated Receptor δ Activity Affect Fatty Acid-controlled Adipose Differentiation* , 2000, The Journal of Biological Chemistry.
[44] B. Corkey,et al. Octanoate attenuates adipogenesis in 3T3-L1 preadipocytes. , 2002, The Journal of nutrition.
[45] P. Grimaldi,et al. Establishment of preadipocyte clonal line from epididymal fat pad of ob/ob mouse that responds to insulin and to lipolytic hormones. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[46] M. Reilly,et al. Biosynthesis of 15-deoxy-delta12,14-PGJ2 and the ligation of PPARgamma. , 2003, The Journal of clinical investigation.
[47] S. Mandrup,et al. Adipogenesis: forces that tip the scales , 2002, Trends in Endocrinology & Metabolism.
[48] I. Castan-Laurell,et al. Understanding adipose tissue development from transgenic animal models. , 2002, Journal of lipid research.
[49] S. Mandrup,et al. Isomer-specific regulation of metabolism and PPARgamma signaling by CLA in human preadipocytes. , 2003, Journal of lipid research.
[50] P. Grimaldi,et al. The roles of PPARs in adipocyte differentiation. , 2001, Progress in lipid research.
[51] J. M. Brown,et al. Conjugated linoleic acid in humans: regulation of adiposity and insulin sensitivity. , 2003, The Journal of nutrition.
[52] J. Gimble,et al. Modulation of the murine peroxisome proliferator-activated receptor gamma 2 promoter activity by CCAAT/enhancer-binding proteins. , 2000, The Journal of biological chemistry.
[53] C. Dani,et al. The human adipose tissue is a source of multipotent stem cells. , 2005, Biochimie.
[54] H. Zulewski,et al. Autocrine/paracrine role of inflammation-mediated calcitonin gene-related peptide and adrenomedullin expression in human adipose tissue. , 2005, Endocrinology.
[55] K. Kim,et al. Pref-1 and ADSF/Resistin: Two Secreted Factors Inhibiting Adipose Tissue Development , 2002, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[56] G. Serrero,et al. Paracrine regulation of adipose differentiation by arachidonate metabolites: prostaglandin F2 alpha inhibits early and late markers of differentiation in the adipogenic cell line 1246. , 1992, Endocrinology.
[57] R. Evans,et al. Peroxisome-Proliferator-Activated Receptor δ Activates Fat Metabolism to Prevent Obesity , 2003, Cell.
[58] B. Walker,et al. Understanding the Role of Glucocorticoids in Obesity: Tissue-Specific Alterations of Corticosterone Metabolism in Obese Zucker Rats1. , 2000, Endocrinology.
[59] A. Garg,et al. Acquired and inherited lipodystrophies. , 2004, The New England journal of medicine.
[60] A. Bradley,et al. Impaired energy homeostasis in C/EBP alpha knockout mice , 1995, Science.
[61] D. Ron,et al. Tumor necrosis factor-induced reversal of adipocytic phenotype of 3T3-L1 cells is preceded by a loss of nuclear CCAAT/enhancer binding protein (C/EBP). , 1992, The Journal of clinical investigation.
[62] Q. Tong,et al. Function of GATA transcription factors in preadipocyte-adipocyte transition. , 2000, Science.
[63] J. Ntambi,et al. Adipocyte differentiation and gene expression. , 2000, The Journal of nutrition.
[64] J. Auwerx,et al. SRC-1 and TIF2 Control Energy Balance between White and Brown Adipose Tissues , 2002, Cell.
[65] Sung Keun Kang,et al. Evidence of a Pluripotent Human Embryonic Stem Cell Line Derived from a Cloned Blastocyst , 2004, Science.
[66] P. Grimaldi,et al. Expression of Peroxisome Proliferator-activated Receptor PPARδ Promotes Induction of PPARγ and Adipocyte Differentiation in 3T3C2 Fibroblasts* , 1999, The Journal of Biological Chemistry.
[67] H. Sul,et al. Pref-1, a protein containing EGF-like repeats, inhibits adipocyte differentiation , 1993, Cell.
[68] J. Engelman,et al. Constitutively Active Mitogen-activated Protein Kinase Kinase 6 (MKK6) or Salicylate Induces Spontaneous 3T3-L1 Adipogenesis* , 1999, The Journal of Biological Chemistry.
[69] Z. Wu,et al. Induction of peroxisome proliferator-activated receptor gamma during the conversion of 3T3 fibroblasts into adipocytes is mediated by C/EBPbeta, C/EBPdelta, and glucocorticoids , 1996, Molecular and cellular biology.
[70] W. Garvey,et al. Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation Published, JLR Papers in Press, April 16, 2005. DOI 10.1194/jlr.M400373-JLR200 , 2005, Journal of Lipid Research.
[71] Triona Goode,et al. C/EBPα Arrests Cell Proliferation through Direct Inhibition of Cdk2 and Cdk4 , 2001 .
[72] L. Fajas. Adipogenesis: a cross-talk between cell proliferation and cell differentiation , 2003, Annals of medicine.
[73] H. Sul,et al. A Cysteine-rich Adipose Tissue-specific Secretory Factor Inhibits Adipocyte Differentiation* , 2001, The Journal of Biological Chemistry.
[74] S. Akira,et al. Defective adipocyte differentiation in mice lacking the C/EBPβ and/or C/EBPδ gene , 1997 .
[75] V. Chatterjee,et al. HIV protease inhibitors block human preadipocyte differentiation, but not via the PPARgamma/RXR heterodimer. , 2000, The Journal of endocrinology.
[76] B. Spiegelman,et al. C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway. , 2002, Genes & development.
[77] K. Chien,et al. PPARγ Is Required for Placental, Cardiac, and Adipose Tissue Development , 1999 .
[78] X. Chen,et al. Structural organization of mouse peroxisome proliferator-activated receptor gamma (mPPAR gamma) gene: alternative promoter use and different splicing yield two mPPAR gamma isoforms. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[79] A. Hamsten,et al. Expression of adipogenic transcription factors, peroxisome proliferator-activated receptor gamma co-activator 1, IL-6 and CD45 in subcutaneous adipose tissue in lipodystrophy associated with highly active antiretroviral therapy , 2003, AIDS.
[80] Charlotte A Peterson,et al. Wnt10b deficiency promotes coexpression of myogenic and adipogenic programs in myoblasts. , 2005, Molecular biology of the cell.
[81] P. Arner. Insulin resistance in type 2 diabetes -- role of the adipokines. , 2005, Current molecular medicine.
[82] H. Sul,et al. Inhibition of adipogenesis and development of glucose intolerance by soluble preadipocyte factor-1 (Pref-1). , 2003, The Journal of clinical investigation.
[83] A. Strosberg,et al. Human immortalized brown adipocytes express functional beta3-adrenoceptor coupled to lipolysis. , 1997, Journal of cell science.
[84] D. Cameron,et al. Glucocorticoid receptors in human preadipocytes: regional and gender differences. , 2000, The Journal of endocrinology.
[85] A. Sadikot,et al. Isolation of multipotent adult stem cells from the dermis of mammalian skin , 2001, Nature Cell Biology.
[86] R. Derynck,et al. Roles of Autocrine TGF-β Receptor and Smad Signaling in Adipocyte Differentiation , 2000, The Journal of cell biology.
[87] R. Somwar,et al. An Inhibitor of p38 Mitogen-activated Protein Kinase Prevents Insulin-stimulated Glucose Transport but Not Glucose Transporter Translocation in 3T3-L1 Adipocytes and L6 Myotubes* , 1999, The Journal of Biological Chemistry.
[88] Kunihiro Matsumoto,et al. Cytokines suppress adipogenesis and PPAR-γ function through the TAK1/TAB1/NIK cascade , 2003, Nature Cell Biology.
[89] C. Dani,et al. Prostacyclin IP receptor up-regulates the early expression of C/EBPβ and C/EBPδ in preadipose cells , 2000, Molecular and Cellular Endocrinology.
[90] J. Ntambi,et al. Preadipocyte differentiation blocked by prostaglandin stimulation of prostanoid FP2 receptor in murine 3T3-L1 cells. , 1996, Differentiation; research in biological diversity.
[91] B. Spiegelman,et al. Differential activation of adipogenesis by multiple PPAR isoforms. , 1996, Genes & development.
[92] P. Grimaldi,et al. New factors in the regulation of adipose differentiation and metabolism , 2002, Current opinion in lipidology.
[93] A. Wolffe,et al. PPARγ knockdown by engineered transcription factors: exogenous PPARγ2 but not PPARγ1 reactivates adipogenesis , 2002 .
[94] C. Dani,et al. Differentiation of embryonic stem cells into adipocytes in vitro. , 1997, Journal of cell science.
[95] M. Wabitsch,et al. The role of growth hormone/insulin-like growth factors in adipocyte differentiation. , 1995, Metabolism: clinical and experimental.
[96] G. Barish,et al. PPARs and the complex journey to obesity , 2004, Nature Medicine.
[97] Satoshi Tanaka,et al. PPARγ Mediates High-Fat Diet–Induced Adipocyte Hypertrophy and Insulin Resistance , 1999 .
[98] Min Zhu,et al. Human adipose tissue is a source of multipotent stem cells. , 2002, Molecular biology of the cell.
[99] J. Reusch,et al. CREB Activation Induces Adipogenesis in 3T3-L1 Cells , 2000, Molecular and Cellular Biology.
[100] H. Sul,et al. Understanding adipocyte differentiation. , 1998, Physiological reviews.
[101] B. Porse,et al. E2F Repression by C/EBPα Is Required for Adipogenesis and Granulopoiesis In Vivo , 2001, Cell.
[102] J. Capeau,et al. Some HIV protease inhibitors alter lamin A/C maturation and stability, SREBP-1 nuclear localization and adipocyte differentiation , 2003, AIDS.
[103] T. Fujiwara,et al. Troglitazone prevents the inhibitory effects of inflammatory cytokines on insulin-induced adipocyte differentiation in 3T3-L1 cells. , 1994, Endocrinology.
[104] N. Bresolin,et al. Cell Therapy of α-Sarcoglycan Null Dystrophic Mice Through Intra-Arterial Delivery of Mesoangioblasts , 2003, Science.
[105] B. Spiegelman,et al. Cross-Regulation of C/EBPα and PPARγ Controls the Transcriptional Pathway of Adipogenesis and Insulin Sensitivity , 1999 .
[106] H. Green,et al. Formation of normally differentiated subcutaneous fat pads by an established preadipose cell line , 1979, Journal of cellular physiology.
[107] B. Corkey,et al. Medium-chain oil reduces fat mass and down-regulates expression of adipogenic genes in rats. , 2003, Obesity research.
[108] N. Ahn,et al. Mitogen-activated protein kinase activation is not necessary for, but antagonizes, 3T3-L1 adipocytic differentiation , 1997, Molecular and cellular biology.
[109] H. Green,et al. Spontaneous heritable changes leading to increased adipose conversion in 3T3 cells , 1976, Cell.
[110] R. Umek,et al. Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. , 1991, Genes & development.
[111] S. Kachman,et al. Adipose depletion and apoptosis induced by trans-10, cis-12 conjugated linoleic Acid in mice. , 2002, Obesity research.
[112] H. Sul,et al. Mice Lacking Paternally Expressed Pref-1/Dlk1 Display Growth Retardation and Accelerated Adiposity , 2002, Molecular and Cellular Biology.
[113] Haiyan Xu,et al. Transmembrane Tumor Necrosis Factor (TNF)-α Inhibits Adipocyte Differentiation by Selectively Activating TNF Receptor 1* , 1999, The Journal of Biological Chemistry.
[114] S. Farmer,et al. Activation of MEK/ERK Signaling Promotes Adipogenesis by Enhancing Peroxisome Proliferator-activated Receptor γ (PPARγ) and C/EBPα Gene Expression during the Differentiation of 3T3-L1 Preadipocytes* , 2002, The Journal of Biological Chemistry.
[115] M. Dieudonné,et al. In Vitro Suppression of the Lipogenic Pathway by the Nonnucleoside Reverse Transcriptase Inhibitor Efavirenz in 3T3 and Human Preadipocytes or Adipocytes* , 2004, Journal of Biological Chemistry.
[116] J. Gimble,et al. Regulation of bone marrow stromal cell differentiation by cytokines whose receptors share the gp130 Protein , 1994, Journal of cellular biochemistry.
[117] M. Lazar,et al. Transcriptional control of adipogenesis. , 2003, Annual review of nutrition.
[118] R. Hammer,et al. Hepatic fibrosis, glomerulosclerosis, and a lipodystrophy-like syndrome in PEPCK-TGF-beta1 transgenic mice. , 1997, The Journal of clinical investigation.
[119] C. Dani,et al. Adipocyte differentiation of multipotent cells established from human adipose tissue. , 2004, Biochemical and biophysical research communications.
[120] M. Lazar,et al. Retinoic acid blocks adipogenesis by inhibiting C/EBPbeta-mediated transcription , 1997, Molecular and cellular biology.
[121] O. MacDougald,et al. The Role of C/EBP Genes in Adipocyte Differentiation* , 1998, The Journal of Biological Chemistry.
[122] H. Green,et al. An established pre-adipose cell line and its differentiation in culture. , 1974, Cell.
[123] H. Lorenz,et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. , 2001, Tissue engineering.
[124] M. Wabitsch,et al. Characterization of a human preadipocyte cell strain with high capacity for adipose differentiation , 2001, International Journal of Obesity.
[125] B. Lévy,et al. Plasticity of Human Adipose Lineage Cells Toward Endothelial Cells: Physiological and Therapeutic Perspectives , 2004, Circulation.
[126] B. Spiegelman,et al. Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor , 1994, Cell.
[127] C. Flexner,et al. Suppression of Preadipocyte Differentiation and Promotion of Adipocyte Death by HIV Protease Inhibitors* , 2000, The Journal of Biological Chemistry.